Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s footer revision/version indicator is updated from v3.5.2 to v3.5.3, reflecting a minor site release without changing the underlying study details.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check60 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3. There are no changes to the displayed study details or page content.SummaryDifference0.1%

- Check88 days agoChange DetectedA new site revision tag 'Revision: v3.4.2' was added. The deletions remove an operating-status notice and a prior revision tag ('Revision: v3.4.1'), which are administrative updates and do not change study content.SummaryDifference0.4%

- Check96 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.